Catinazzo Thomas's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Mar 31, 2025
- Accession no.
- 0000950170-25-047725
- Filed
- Mar 31, 2025
- Trade date
- Mar 27, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $13.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Catinazzo ThomasCIK 0001818261 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Common Stock | SSaleDisposed | −298 | $2.84 | −$846.32 | 379,133 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −4,566 | $2.84 | −$12,967.44 | 374,567 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.